Total revenues for the quarter ended at MNOK 109.8 (MNOK 82.5) and includes MNOK 5.3 granted by the U.S. Paycheck Protection Program related to COVID-19.
Total revenues for the first half ended at MNOK 212.4 (185.6). Operating profit (EBIT) for the quarter ended at MNOK 42.7 (MNOK 27.7), a 54.0% increase and by far the best EBIT for a quarter ever. Operating profit for the first half ended at MNOK 71.7 (MNOK 52.5), a 36.7% increase. This is also the best operating profit for the first half ever.

High growth in number of procedures in the USA with 50% – as well as consumable probe sales growth with 35% – reflect an increasing number of surgeries being performed and continuing recovery from the COVID pandemic.

See the full presentation and report below.

Q2 and 1st half report 2021 presentation

Q2 and 1st half report 2021